Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

NCT05485909 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer

NCT01271192 ·Status: UNKNOWN ·Phase: NA

Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer

NCT06617052 ·Status: NOT_YET_RECRUITING

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

NCT01549067 ·Status: UNKNOWN

Observational Study on the Patients With Rectal Cancer

NCT02312284 ·Status: COMPLETED

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients

NCT06621173 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

NCT04030260 ·Status: UNKNOWN ·Phase: PHASE2

Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer

NCT06314737 ·Status: COMPLETED

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

NCT05871762 ·Status: RECRUITING

Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

NCT05414461 ·Status: COMPLETED ·Phase: PHASE2

Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer

NCT07154173 ·Status: RECRUITING

Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer

NCT05671809 ·Status: NOT_YET_RECRUITING

Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

NCT06040021 ·Status: COMPLETED

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

NCT01671891 ·Status: UNKNOWN

Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis

NCT05057052 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer

NCT01211210 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

NCT06255379 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

High Dose Radiotherapy for the Treatment of Rectal Cancer

NCT03541304 ·Status: COMPLETED

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

NCT05148767 ·Status: RECRUITING ·Phase: PHASE4

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

NCT02350530 ·Status: COMPLETED ·Phase: PHASE2

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

NCT02860234 ·Status: COMPLETED

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

NCT05640726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma

NCT02002416 ·Status: UNKNOWN

Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer

NCT06879197 ·Status: COMPLETED

Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients

NCT02149784 ·Status: UNKNOWN ·Phase: PHASE3